Advancing Hepatitis B Cure: A Closer Look at Barinthus Bio's VTP-300 Project
Infections | 15 May 2024
Protecting Good Bacteria with Adjusted Antibiotic Doses During Treatment
Infections | 12 October 2023
WHO Endorses Second Malaria Vaccine: Matrix-M is Cheaper and Efficient
Infections | 10 October 2023
Newly Discovered Bird Flu Mutation Sparks Global Pandemic Fear
Infections | 4 September 2023
Subscribe for the latest news and events
Most Popular
Improving Everolimus Safety in Oncology: Missed Opportunities in Risk Minimization
Targeting the ‘Don’t Eat Me’ Signal: The Future of Macrophage Checkpoint Inhibitors
FDA Approves Wegovy to Reduce Risk of Heart Problems in Obese Adults
A New Era in Liver Disease: FDA Approves First Medication 'Rezdiffra' for NASH
Zongertinib Gains FDA Accelerated Approval for HER2+ NSCLC with 75% ORR
Exploring the Transformative Power of AI in Drug Discovery: A report by S&P Global
NETTER-2 Trial: Lutathera Cuts Risk of Death by 72% in Neuroendocrine Tumor Treatment
EpCAM-Targeting ADC CX-2051 Shows Promising Efficacy in Advanced Colorectal Cancer
FDA Grants Accelerated Approval to Semaglutide for MASH with Liver Fibrosis
Bayer Poised for Landmark Year with Blockbuster Treatment Advances Across Key Diseases
Transformative One-Time Gene Therapy: FDA Approves Pfizer's BEQVEZ, for Hemophilia B
NEJM Study Confirms Low-Dose Aspirin Halves Recurrence in Colorectal Cancer
FDA Approves Groundbreaking CAR T Cell Therapy, Abecma, for Multiple Myeloma
New Horizon in Food Allergy Treatment: FDA Approves Xolair for All Ages
FDA Approves Carvykti as Targeted CAR-T Cell Therapy for Multiple Myeloma
